🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

This will be very good. Knowing Max Parmar this will cover very innovative and more efficient designs for randomized trials. Strongly recommend. CReDO ACORD Initiative

Wonderful inaugural session #ASGCR24 Early Career Investigator Day! 🔸@OphiraG Challenges to conduct research in LMICs 👩🏻‍⚕️🌍👨🏻‍⚕️ 🔸Priya Ranganathan CReDo Workshop achievements in India CReDO NationalCancerGrid 🔸@iVikVS strategies to improve screening & tx cervix cancer

And, CReDO 2025 is on! 76 early career researchers, 45 faculty, 17 biostatisticians and 12 patient advocates learning cancer research methods together! NationalCancerGrid

We kickstart the CReDO with one of the most important aspects of research methods training - patient and public involvement in medical research from the inimitable Richard Stephens

WomenLift Health ladies at the CReDO Manju Sengar Priya Ranganathan

The first patient advocate from India in the house CReDO. The very inspiring Vivek Tomar Vivek Tomar #RiseToSurviveCancer

Incredibly moving talk from Vivek Tomar #RiseToSurviveCancer at the CReDO Reminding all of us about why we do what we do. Patients first, always.

And here we go! Stellar Day 1 CReDO in picturesque Lonavala! Energetic start by Richard Stephens (patient advocate) and a heartwarming end by Vivek Tomar #RiseToSurviveCancer. Amazing mentors Matt Sydes Pramesh CS Priya Ranganathan ! And new friends Dr. Karan Sood !

Great to finally meet you in person, Martin! Martin Stockler And Pankaj Kumar Panda, we really missed you, hope to catch up soon! CReDO #Credo25

Deeply grateful to Pramesh CS , Priya Ranganathan & CReDO team for not just giving a seat to a patient research advocate like me, but the honor of delivering the keynote. A huge thanks to the hundreds of researchers who traveled from across the world to this really important

The CReDO is happening now in Mumbai! Two years and I still remember how life-changing it was. There is definitely a life before CREDO and a life after CREDO—and the difference is real. If you’re there now, make the most of it! Pramesh CS Priya Ranganathan Tata Memorial Hospital

Six days of incredible work from the participants, our patient advocates and faculty CReDO and we're at the penultimate day when we present the top 10 protocols developed. Tough to choose just 10 from 77 protocols developed in just 6 days!

Very grateful to all our supporters including NationalCancerGrid St. Jude ASCO Memorial Sloan Kettering Cancer Center UCSF School of Medicine IAEA - International Atomic Energy Agency ⚛️ City Cancer Challenge The Lancet Oncology NatureRevClinOncol King's College London EORTC R4HC-MENA Axis Bank

NationalCancerGrid St. Jude ASCO Memorial Sloan Kettering Cancer Center UCSF School of Medicine IAEA - International Atomic Energy Agency ⚛️ City Cancer Challenge The Lancet Oncology NatureRevClinOncol King's College London EORTC R4HC-MENA Axis Bank

NationalCancerGrid St. Jude ASCO Memorial Sloan Kettering Cancer Center UCSF School of Medicine IAEA - International Atomic Energy Agency ⚛️ City Cancer Challenge The Lancet Oncology NatureRevClinOncol King's College London EORTC R4HC-MENA Axis Bank

Thrilled to be attending CReDO once again, this time for a dedicated 2-day session on Biostatistics! Grateful for the opportunity to deepen my knowledge and contribute to meaningful conversations on statistical methodologies in clinical research." #biostatistics

Pramesh CS CReDO NationalCancerGrid ASCO IAEA - International Atomic Energy Agency ⚛️ National Cancer Institute @NCIGlobalHealth The Lancet Oncology EORTC City Cancer Challenge NatureRevClinOncol St. Jude MRC Clinical Trials Unit at UCL I am very proud of being from the Credo family as prior student. This is such an incredible opportunity for the 76 young researchers learning from 🔝 faculty. For many additional CReDO editions to come!

And that's a wrap on an intense week CReDO! Learnt the beauty of meaningful research from an all-star faculty! A big shout out to Pramesh CS , Priya Ranganathan Manju Sengar , Shivakumar Thiagarajan and Prof Girish for organising this! NationalCancerGrid

And the group (E) that became family! Matt Sydes Vivek Tomar #RiseToSurviveCancer, Chris Booth (founder of Common Sense Oncology ), and Prof Ramakrishna (Cancer Institute (WIA), Chennai ) shaped our research proposals with unparalleled patience and diligence! CReDO NationalCancerGrid

It’s not just about work but joyful moments like these😀CReDO